Table 1

Descriptive characteristics of participants of the DLCST at baseline in 2004
Characteristics Respondents Intervention Control p-value
N = 4,104 N = 2,052 N = 2,052
Gender, women, number, (%) 4,104 905 (44.10) 932 (45.42) 0.397
Mean age, years 4,104 57.35 57.31 0.807
Age group (above mean: 57.3 years) (%) 4,104 1,001 (48.78) 972 (47.37) 0.365
Civic status, living alone, number, (%) 4,076 586 (28.58) 587 (28.60) 0.980
Mean income per year (DKK) 4,100 316,910 315,814 0.859
SES group, number, (%) 4,100
Below 250,000 DKK/year 754 (36.74) 759 (36.99)
250–350,000 DKK/year 650 (31.68) 643 (31.34)
Above 350,000 DKK/year 648 (31.58) 650 (31.68) 0.972
Charlson co-morbidity index at baseline, number, (%) 4,104
0 1,717 (83.67) 1,693 (82.50) 0.336
1 235 (11.45) 238 (11.60)
>1 100 (4.87) 121 (5.90)
Prescription of AD or AX medication at least once during the 4 months period before baseline, number, (%) 4,104 269 (13.11) 277 (13.50) 0.713
Prescription of AD or AX medication at least once during the 2 years period before baseline, number, (%) 4,104 483 (23,54) 502 (24,46) 0.487

Kaerlev et al.

Kaerlev et al. BMC Cancer 2012 12:188   doi:10.1186/1471-2407-12-188

Open Data